(3-methyl-6-morpholinobenzo[g]pyrrolo[2,1-a]phthalazine-1,2-diyl)dimethanol

ID: ALA4854342

PubChem CID: 164613463

Max Phase: Preclinical

Molecular Formula: C22H23N3O3

Molecular Weight: 377.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1c(CO)c(CO)c2c3cc4ccccc4cc3c(N3CCOCC3)nn12

Standard InChI:  InChI=1S/C22H23N3O3/c1-14-19(12-26)20(13-27)21-17-10-15-4-2-3-5-16(15)11-18(17)22(23-25(14)21)24-6-8-28-9-7-24/h2-5,10-11,26-27H,6-9,12-13H2,1H3

Standard InChI Key:  IUTQEYIIYMIJHJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 32  0  0  0  0  0  0  0  0999 V2000
   29.0708   -4.5688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0696   -5.3883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7777   -5.7973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7759   -4.1599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4845   -4.5652    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4853   -5.3842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1938   -5.7913    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.1882   -4.1550    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8973   -4.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8991   -5.3821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3207   -4.5553    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6059   -4.1427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3225   -5.3791    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.6116   -5.7936    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7862   -6.5979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6051   -6.6803    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9364   -5.9271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6030   -3.3255    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.7350   -5.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0168   -7.3862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2420   -7.2075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8340   -7.3826    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4979   -7.9836    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.3132   -2.9170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3123   -2.1034    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6050   -1.6935    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.8969   -2.1033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8961   -2.9231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7 10  2  0
  9  8  2  0
  8  5  1  0
  9 10  1  0
  9 12  1  0
 10 14  1  0
 13 11  1  0
 11 12  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 13  1  0
 12 18  1  0
 17 19  1  0
 16 20  1  0
 15 21  1  0
 20 22  1  0
 21 23  1  0
 18 24  1  0
 18 28  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4854342

    ---

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CEM-VLB (63 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H460 (60772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H520 (551 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H226 (44470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H2170 (227 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1650 (1118 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1417 (138 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H211 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H146 (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H82 (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H526 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
786-0 (47912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.44Molecular Weight (Monoisotopic): 377.1739AlogP: 2.77#Rotatable Bonds: 3
Polar Surface Area: 70.23Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.35CX LogP: 2.63CX LogD: 2.63
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -0.74

References

1. Chen TL, Patel AS, Jain V, Kuppusamy R, Lin YW, Hou MH, Su TL, Lee TC..  (2021)  Discovery of Oral Anticancer 1,2-Bis(hydroxymethyl)benzo[g]pyrrolo[2,1-a]phthalazine Hybrids That Inhibit Angiogenesis and Induce DNA Cross-Links.,  64  (17.0): [PMID:34459195] [10.1021/acs.jmedchem.0c01733]

Source